Please login to the form below

tuberculosis

This page shows the latest tuberculosis news and features for those working in and with pharma, biotech and healthcare.

Bicycle Therapeutics to tackle AMR with government funding

AMR developed as a consequence of overusing antibiotics and as a result, certain strains of diseases, such as tuberculosis and Staphylococcus aureus are now unresponsive to the drugs due to the

Latest news

Chinese biotechs aim PD-L1 antibody at hepatitis B

B virus (HBV), HIV and tuberculosis.
Evotec says Sanofi deal makes it anti-infectives powerhouse

regulatory approvals of course – and that will give it “the highest qualified translational footprint in infectious disease research globally.” It will focus initially on antimicrobial resistant (AMR) infections, tuberculosis, and malaria,
Gates’ non-profit biotech for poverty diseases sets out its stall at BIO

Dedicated to the development of products to treat malaria, tuberculosis and diarrhoeal diseases and with a war chest from its parent of $273m over four years, Gates MRI has been in
Pharma must do more on antibiotic resistance, Davos meeting hears

for AMR and bring them to market responsibly,” citing the case of J&J’s new tuberculosis drug bedaquiline which is available in 100 countries with tight control of access.
J&J expands its TB research programme

Johnson and Johnson (J&J) has partnered with the Institute of Microbial Technology (IMTECH), part of the Council of Scientific and Industrial Research (CSIR), to develop new treatments for tuberculosis (TB).

More from news
Approximately 16 fully matching, plus 108 partially matching documents found.

Latest Intelligence

Biotech profile: Tom Evans, CEO, Vaccitech.

In September 2010 he joined Aeras, a non-profit Product Development Partnership with a mission to develop global tuberculosis vaccines, as the Chief Scientific Officer, and became CEO in February 2013.
Combining therapies and combining research

Combination therapy. Antibiotic Combination Therapy was developed in 1952 for the treatment of tuberculosis. ... Combination therapy is the norm in the treatment of many cancers and viral infections such as HIV and even some bacterial diseases such as
30 Women Leaders in UK Healthcare (part 3)

and tuberculosis around the world.
The cultural construction of illness

and ‘consumptive’ appearance, driven by the perception of a link between tuberculosis and creativity.
Reactivating drug research programmes

One research-led breakthrough to hit the headlines involves the use of genome sequencing to isolate different strains of tuberculosis (TB), allowing the disease to be diagnosed more quickly.

More from intelligence
Approximately 0 fully matching, plus 17 partially matching documents found.

Latest appointments

Former Merck & Co exec to lead Seres

In total Dr Pomerantz has been involved with the development of eight approved drugs for infectious diseases, covering HIV, hepatitis C and tuberculosis.
GlycoVaxyn appoints Gerd Zettlmeissl as chairman

He currently serves on the boards of several biotechnology companies including Aeras, an organisation dedicated to the development of tuberculosis vaccines.
Former PEPFAR head Mark Dybul to lead the Global Fund

Joins at time of change for the AIDS, tuberculosis and malaria focused non-profit organisation. ... The Global Fund to Fight AIDS, Tuberculosis and Malaria has appointed renowned AIDS expert Dr Mark Dybul as executive director.

More from appointments
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest from PMHub

World AIDS Day 2018: Fighting the stigma surrounding HIV

2. Characterised by very low levels of CD4+ T cells, and the presence of AIDS-related pathologies (such as tuberculosis and Kaposi’s sarcoma), the diagnosis of AIDS marks just how
Could ketamine be the next big thing in depression?

Doctors noticed that tuberculosis patients treated with isoniazid showed signs of improved mood.
Exploring MINT: Part 4 - Turkey

due to migration to the urban centres of the west. In Eastern Turkey, outbreaks of communicable diseases such as tuberculosis are still occurring. Pharma investment therefore remains focused on the western

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Account Director - Medical Communications - London / South East: Excellent Salary and Benefits on offer

Senior Account Executive – Account Manager – Healthcare Advertis...: £32000 - £43000 Bonus Benfits

Account Director, Healthcare Communications: Salary TBC

FREELANCE Account Director – Healthcare Advertising – London – 3...: Competitive Daily Rates

Account Director - Healthcare Advertising - London - 2 DAYS HOME...: £50000 - £70000

Account Director – UK Office: Excellent salary and benefits

Account Director – London based Medical Communications Agency: Excellent Remuneration Package

FREELANCE Medical Writer (Initial 2/ 3 months term) - London Off...: Excellent Daily Rate

Strategic Planner, Healthcare Advertising Agency: Salary TBC

Senior Medical Writer, Healthcare Advertising Agency: £45, 000 – £50, 000

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Healthcircle

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Latest intelligence

The relevance of patient perspectives to value: Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?: Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
The evolution of real-world studies: How industry and regulators are using real-world data...